Language: BG BG
nav.cta
← Back to results
Active (not recruiting) Phase 1 2025-522782-30-00

A study to learn if bimekizumab given in different ways is safe and moves similarly throughout the body over time in adults

Phase 1 – testing safety in a small group of people
Conditions: CCI

Sponsor: UCB Biopharma

trial.available_in: БГ
Overview
Trial status: Authorised
Who can participate
Age group: 18-64 years, 65+ years Gender: Female, Male Target enrollment: 293 participants
Locations 6
Bulgaria (1)
Croatia (1)
Czech Republic (1)
Germany (1)
Poland (1)
Slovakia (1)
Technical details
Status
Active (not recruiting)
Phase
Phase 1
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
16.03.2026
Registry ID
2025-522782-30-00
Source
euclinicaltrials.eu
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.